FDA Inspection 1108572 — Astellas Pharma US Inc.
The FDA completed an inspection of Astellas Pharma US Inc. on Oct 4, 2019 in Northbrook, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 4, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Northbrook, IL (United States)
Additional Details
Bioanalytical BA/BE